Vladimír Vonka
-
The Relationship of Kynurenine and Neopterin Levels and Their Association with a Selection of Other Immune Markers in Chronic Myeloid Leukaemia Patients
Vladimír Vonka, M. Petráčková, Z. Humlová, H. Klamová, L. Kujovská-Krčmová, M. Dušková, B. Procházka
2016, Vol. 62, Issue 6, pp. 235-240 -
Immunological Profiles of Patients with Chronic Myeloid Leukaemia. I. State before the Start of Treatment
Zuzana Humlová, H. Klamová, I. Janatková, P. Šandová, I. Šterzl, E. Sobotková, E. Hamšíková, C. Haškovec, M. Písačka, P. Cetkovský, K. Michalová, E. Faber, Z. Heřmanová, M. Ordeltová, K. Roubalová, Z. Roth, Vladimír Vonka
2006, Vol. 52, Issue 3, pp. 47-58 -
Characteristic of Two Mouse bcr-abl-Transformed Cell Lines: I. General Properties of the Cells
E. Sobotková, V. Ludvíková, M. Petráčková, M. Dušková, K. Smetana, F. Jelínek, I. Marinov, Vladimír Vonka
2005, Vol. 51, Issue 1, pp. 12-18
The following name might also represent this author:
V. Vonka
-
Characteristics of Two Mouse bcr-abl-Transformed Cell Lines. II. Pathological Lesions Induced in Mice
František Jelínek, E. Sobotková, V. Vonka
2005, Vol. 51, Issue 4, pp. 93-102 -
Immunogenicity of Dendritic Cell-Based HPV16 E6/E7 Peptide Vaccines: CTL Activation and Protective Effects
Marie Indrová, M. Reiniš, J. Bubeník, T. Jandlová, J. Bieblová, V. Vonka, J. Velek
2004, Vol. 50, Issue 6, pp. 184-193 -
MHC Class I+ and Class I- HPV16-Associated Tumours Expressing the E7 Oncoprotein Do Not Cross-react in Immunization/Challenge Experiments
Jana Šímová, R. Mikyšková, V. Vonka, J. Bieblová, J. Bubeník, T. Jandlová
2003, Vol. 49, Issue 6, pp. 230-234 -
Adjuvant Cytokine Treatment of Minimal Residual Disease after Surgical Therapy in Mice Carrying HPV16-Associated Tumours: Cytolytic Activity of Spleen Cells from Tumour Regressors
Marie Indrová, R. Mikyšková, T. Jandlová, V. Vonka, J. Bubeník, J. Bieblová
2003, Vol. 49, Issue 6, pp. 217-222
